1 To whom correspondence should be addressed significance in the growth of leiomyomata (Smith, 1993) , and The two forms of the progesterone receptor, PR-A and PRmight act as a growth promotor as in breast glandular tissue. B, are independently regulated at the transcriptional level, Kawaguchi et al. (1989) showed that the mitotic activity in and show distinct responses to progesterone antagonists.
fibroids is higher in the secretory phase than in the proliferative We were interested in possible differences in the PR-A to phase of the cycle. Myomas from post-menopausal women PR-B ratio between uterine myometrium and leiomyomata receiving oestrogen replacement therapy demonstrated low (fibroid), that might influence the response of fibroids proliferative activity, whereas those from women receiving to progesterone agonists and antagonists, and thus have combined oestrogen ϩ progestin replacement demonstrated a consequences for the treatment of this condition. Fibroid proliferative index equal to that observed in pre-menopausal and adjacent normal myometrium were obtained from 11
women (Lamminen et al., 1992) . Myomas and myometrial women undergoing hysterectomy. Immunohistochemistry cells cultured in the presence of oestrogen and progesterone using a monoclonal antibody which recognizes both PR-A appeared more active under the electron microscope than and PR-B showed exclusively nuclear staining, and this cells cultured in oestrogen-containing or control medium was stronger in the leiomyomata than in adjacent myome- (Kawaguchi et al., 1985) . Some of the biological effects of trium. An antibody specific for PR-B gave fainter staining steroid hormones are mediated through polypeptide growth of both tissues. Western blotting confirmed a higher concenfactors (Nelson et al., 1992) . While this has not been demontration of PR in leiomyomata than myometrium in eight strated for progesterone, the level of mRNA encoding the out of 11 cases. In all cases both forms were present, with angiogenic vascular endothelial growth factor (VEGF) is higher a consistent dominance of PR-A over PR-B. However an in the secretory phase than in the proliferative phase of normal RNase protection assay showed that there was no difference myometrium (Harrison-Woolrych et al., 1995) . Also in the between the concentrations of mRNA encoding PR-A and secretory phase of the cycle the level of mRNA encoding PR-B, or between the mRNA concentrations in leiomyepidermal growth factor (EGF) is higher in leiomyomata than omata and normal myometrium. We conclude that the in normal myometrium (Harrison-Woolrych et al., 1994) . observed differences between the levels of immunoreactive
Further support for the role of progesterone in fibroid growth PR in leiomyomata and myometrium may result from postcomes from the study by Murphy et al. (1993) . These authors translational control, and support the use of progesterone showed that treatment for 3 months before surgery with RU antagonists in the treatment of leiomyomata.
486, an antiprogestin, decreased the size of the fibroid by Key words: progesterone receptor/fibroid/protein determina-49%. The efficacy of anti-oestrogenic therapy, such as treatment tion/messenger RNA/RU 486 with GnRH agonists, could therefore be due to their suppression of ovulation which prevents the progesterone peak in the luteal phase. This is supported by the observation of Friedman et al. (1990) who showed that women who were treated with a Introduction combination of GnRH agonists and progestin did not show any significant regression of their leiomyomata. Uterine leiomyomata (fibroids) are common benign tumours of uterine smooth muscle cells. Although not malignant,
The progesterone receptor (PR) is unusual in the nuclear receptor superfamily in that two isoforms of receptor exist. they grow rapidly and are the most common indication for hysterectomy. The underlying cause of leiomyomata is not Receptor A (PR-A) is 94 kDa and receptor B (PR-B) is 120 kDa (Horwitz and Alexander, 1983) . PR-A and PR-B known but it is clear that ovarian steroid hormones play a role in their growth. Traditionally, medical therapies have focused result from translation of two different mRNA populations which arise by transcription from alternative initiation sites on antagonizing the action of oestrogens on the leiomyomata. For example, administration of gonadotrophin-releasing horwithin the same gene. The transcription of the two forms is controlled by two different promoters that are both oestrogenmone (GnRH) agonists suppresses pituitary gonadotrophin pathologist in order to exclude malignant change and the endometrium induced (Kastner et al., 1990a) . In vitro these promoters are from each uterus was dated (Noyes et al., 1950) . regulated independently (Gronemeyer et al., 1991) and this Five pairs of matching leiomyomata and adjacent myometrium suggests that they could be regulated in a tissue-specific were obtained in the proliferative phase, and six pairs in the secretory manner. The exact role of each form is unclear at present; phase. Immediately on collection, tissue specimens consisting of however, in the presence of agonist, PR-A and PR-B are about 0.5 g of fibroid and 0.5 g of normal adjacent myometrium functionally different in vitro. Also, PR isoforms have differenwere rinsed with phosphate buffered saline (PBS) to remove excess tial target gene specificity and may interact differently with a blood, flash-frozen in liquid nitrogen and stored at -70°C until used given promoter (Tora et al., 1988; Kastner et al., 1990b (Estes et al., 1987) . Biotin-streptavidin-peroxidet al., 1991) . does not require the progesterone response element, so that a were obtained from Sigma (Poole, Dorset, UK) and Immobilon (PVDF) from Millipore (Bedford, MA, USA). Enhanced chemigene that is not normally a progesterone target could be luminescence system (ECL-kit), biotinylated molecular weight aberrantly activated (Tung et al., 1993) . PR-A also binds on the ratio of the two forms (Vegeto et al., 1993) .
RPA II kits were from Ambion (Austin, TX, USA). Guanidinium PR-A and PR-B have been reported to be present in chicken thiocyanate was obtained from Gibco-BRL (Uxbridge, UK).
oviduct at equimolar concentrations (Gronemeyer et al., 1987) .
Immunohistochemistry
However PR-B is the only form described in the rabbit genital tract (Loosfelt et al., 1984) . In human cell cultures equimolar From the formalin-fixed embedded tissue, 10 µm sections were cut and mounted onto slides coated with 2% APES (Sigma, St Louis, concentrations for both forms have been reported in the breast MO, USA). Three consecutive sections for each patient were dewaxed cancer cell line T47D (Horwitz and Alexander, 1983) and in xylene and rehydrated through an alcohol series to tap water. endometrial cancer cells (Feil et al., 1988) . In human tissues, Sections were placed in boiling sodium citrate (0.01 M, pH 6) in a a predominance of PR-A in leiomyomata compared with stainless steel pressure cooker and incubated 1 min at maximum myometrium has been suggested but with a limited number of pressure. Endogenous peroxidase activity was destroyed by a 10 min samples (Brandon et al., 1993) . Since progestagen antagonist incubation with 3% hydrogen peroxide at 37°C. Blocking of nontherapy offers several new therapeutic opportunities, it is of specific binding was performed with 10% goat serum in PBS for 1 h. great importance to characterize the receptors which will PR was localized using a mouse monoclonal antibody (NCL-PGR) interact with these drugs (Van Look, 1995) . We therefore which does not distinguish between PR-A and PR-B (used at 1 in 20 decided to examine the concentration of PR in fibroids and in dilution). PR-B was specifically localized using the antibody B30 (mouse monoclonal IgG1, concentration 175 µg/ml). Binding was adjacent normal myometrium and to determine the ratio of the visualized using a goat anti-mouse biotinylated antibody for 1 h, two forms at both the protein and mRNA levels.
followed by streptavidin-peroxidase complex which was detected with diaminobenzidine and hydrogen peroxide. Controls were performed using an isotype-matched irrelevant antibody at the same Materials and methods dilution. No counter-staining was used since this would mask nuclear Subjects staining. The slides were mounted with Depex and staining evaluated by conventional light microscopy. Eleven Caucasian women aged 35-53 years were included in this study. All had regular menstrual cycles and had taken no hormonal Protein analysis by Western blotting medication for at least 3 months prior to the study. They were undergoing hysterectomy for symptomatic leiomyomata at
In order to estimate the relative amount of each form of PR, Western blotting was used. The frozen tissue was homogenized by Polytron Addenbrookes Hospital NHS Trust, Cambridge, UK. Written informed consent was obtained from each patient and the study approved by (Ultra-Turrax T25 from Janke and Kunkel, Staufen, Germany) in 5 ml of lysis buffer (TEG: 10 mM Tris-HCl pH 7.4, 1 mM EDTA the Ethical Committee of the Trust. Each uterus was examined by a and 10 % glycerol) in presence of an antiproteolytic mixture containing century RNA marker from Ambion was used as the molecular weight marker. aprotinin 77 mg/ml, leupeptin 1 mg/l, pepstatin A 1 µg/l, bacitracin
The labelled PR-A/PR-B and GAPDH probes (4 ϫ 10 4 cpm) were 100 µg/ml, PMSF 40 µg/l.
added to 30 µg of each sample RNA. Following hybridization and The homogenate was clarified by centrifugation at 10 000 g for RNase digestion the protected fragments were loaded onto a 6% 20 min and the protein concentration determined (DC-Protein Assay, denaturing polyacrylamide sequencing gel. The gel was fixed, dried Bio Rad, Hemel Hempstead, Herts, UK). 40 µg of protein extracted and autoradiographed at Ϫ70°C with intensifying screens. Following from leiomyomata and adjacent myometrium were separated on 7.5% exposure the film was developed and densitometry was performed SDS-polyacrylamide mini-gels then transferred electrophoretically at on the resultant PR-A, PR-B and GAPDH bands. mRNA from T47D 200 mA for 1 h using a semi dry transfer method (LKB Bromma cells and yeast were our positive and negative controls repectively. Multiphor II) to a PVDF membrane (Immobilon, Millipore), using an LKB continuous buffer without methanol (glycine 39 mM, Tris Statistics 48 mM, sodium dodecyl sulphate 0.0375%). The conditions used for
The paired Wilcoxon rank sum test was applied to the values separation and transfer were chosen after pilot experiments which for evaluation of differences between PR concentrations in the showed that shorter transfer times significantly altered the ratio of leiomyomata and the myometrium. The Wilcoxon rank sum test for PR-A:PR-B in favour of PR-A (the lower molecular weight form).
unpaired samples was used to compare PR amounts in the same Increasing the transfer times from those described above did not alter tissue type for the different phases of the cycle. the observed ratio indicating that transfer was complete. Efficient transfer of both forms is essential for accurate estimation of the ratio.
Results
After blocking for 1 h at 37°C with PBS containing 10% low fat milk powder (Marvel ® ) and 0.1% Tween, the membrane was incubated Immunohistochemistry overnight with the monoclonal anti-PR antibody (Novocastra) at a Using the antibody which recognizes both forms of the PR, dilution 1/100. The membrane was then washed five times with PBS nuclear staining was seen, with a greater number of stained containing 0.1% Tween, incubated for 1 h at room temperature with nuclei present in leiomyomata compared to myometrium. for either of the antibodies. The staining with the irrelevant Total RNA was isolated from~0.5 g frozen tissue pieces using the mouse IgG did not show any staining (data not shown).
guanidinium isothiocyanate method (Chomczynski and Sacchi, 1987) . A probe for use in the RPA was designed to include a region where
Western blotting for PR-A and PR-B
the two transcripts differ. The fragment was generated by PCR To obtain a more quantitative assessment of the levels of (position ϩ732 to ϩ911), on the total PR cDNA (kindly provided immunoreactive PR in the leiomyomata and myometrium and by P.Kastner), the major transcription sites being described as (ϩ1, to estimate accurately the ratio of the different forms of ϩ15 for PR-B, ϩ751, ϩ761, ϩ842 for PR-A) in the sequence receptor, Western blotting was used. The monoclonal antibody described by Kastner et al. (1990a) . The primers used were: 5Ј-NCL-PGR was used since this antibody recognizes a common AGTCCAGTCGTCATGACT-3Ј and 5Ј-CATACCTATCTCCCTGepitope on PR-A and PR-B.
GAC-3Ј. The amplified DNA was then cloned using PCR Script SK(ϩ) and sequenced to confirm its identity. The in-vitro transcription individuals. In the majority of cases (8/11) there was more PR to multiple initiation sites (Kastner et al., 1990a) . The transcription/ in the fibroid tissue than the myometrium ( Figure 3C ). In both labelling reaction was carried out using 60 µCi [ 32 P]UTP (Amersham fibroid and myometrium (11/11 and 10/11 respectively) there International) and the Maxiscript T7 polymerase kit from Ambion was more PR-A than PR-B (1.6-fold) ( Figure 3B, A) . Both of (Austin, TX, USA). To isolate the probe, it was run on a denaturing these differences were highly significant using the Wilcoxon 4% acrylamide gel and the band containing full length probe was test on paired samples (P Ͻ0.01). However, there was no excised. The probe was eluted from the gel in 350 µl of elution buffer apparent change in PR amounts related to the phase of the by incubation overnight at 37°C. A riboprobe for GAPDH was used menstrual cycle.
as an internal standard against which to compare PR-A and PR-B levels. As GAPDH mRNA is more abundant than PR mRNA in all PR-A and PR-B mRNA concentration cells the GAPDH probe was synthesized at 10-fold lower specific To determine whether the increased amounts of PR in leiomyactivity. This ensured that the GAPDH probe could be used in excess and a similar exposure time could be used for both probes. The omata observed by immunocytochemistry and Western blotting Figure 1 . Immunohistochemical staining of progesterone receptor (PR) on cross-section leiomyomata/myometrium. The illustrations are late secretory phase, but the staining has been studied throughout the cycle (data not shown). M indicates myometrium and F fibroid. A, crosssection leiomyomata/myometrium (ϫ100) stained with an antibody recognizing PR-A and PR-B. B, same cross-section (ϫ100) stained with a PR-B specific antibody. C, leiomyomata (ϫ400) stained with an antibody recognizing PR-A and PR-B. D, adjacent myometrium (ϫ400) stained with an antibody recognizing PR-A and PR-B. E, leiomyomata (ϫ400) stained with a PR-B specific antibody. F, adjacent myometrium (ϫ400) stained with an antibody recognizing PR-A and PR-B. were paralleled by changes in the steady state concentrations to the PR-A and PR-B transcripts were summed and reported per unit of GAPDH. We concluded that there was no difference of the mRNA encoding PR-A and PR-B we carried out RNase protection assays. Since the probe used spans the region where between leiomyomata and myometrium in the mRNA expression for either of the forms ( Figure 5A, B) . There was the mRNA differs it allowed the amounts of PR-A and PR-B mRNA to be determined independently in the same RNA no significant fluctuation throughout the cycle in either of the tissues. sample. Previous work has relied on Northern blotting which cannot distinguish the different PR transcripts.
The RPA showed four bands for PR-A as there are several Discussion initiation sites [as described (Kastner et al., 1990a) and confirmed by the primer extension, data not shown]. The doublet
The interactions of progestins, antiprogestins and the two forms of the PR are complex and understanding this is a labelled PR-B in Figure 4 corresponds to the mRNA that have the potential to encode PR-B since they include the ATG at prerequisite to rational clinical treatment. To investigate the possible role of progesterone in the pathogenesis of leiomyompositions 744-746 (numbering according to Kastner et al., 1990a) . The optical densities for all the bands corresponding ata we have determined the ratio of immunoreactive PR-A Rose, 1979). Similarly Otubu et al. (1982) found that the concentration of estradiol was higher in leiomyomata than in normal myometrium and that the conversion of oestradiol to oestrone in leiomyomata was significantly lower when compared to myometrium. All these hypotheses would predict absence of cyclical variation in fibroid PR, which we have observed here, and this is in agreement with previous reports (Chrapusta et al., 1990; Vollenhoven et al., 1994) . This is also consistent with several immunohistochemical studies which described myometrial PR staining with a possible increase of total PR in late proliferative phase but no decline in the late secretory phase (Lessey et al., 1988) or no variation at all (Savouret et al., 1991) . The intensity of PR staining in myometrium has also been described as being similar in menopausal women with or without hormone replacement therapy (Amso et al., 1994) . A third theory to account for the higher amounts of PR would be that for a given circulating oestrogen concentration, its activity is enhanced by a high number of oestrogen receptors (ER), and the high content of PR is a consequence of overexpression of functional ER, as suggested by Brandon et al. (1995) .
The concentration of PR-A was found by Western blot analysis to be higher than that of PR-B in both leiomyomata and myometrium. Thus the possible agonist-like effects that antiprogestins can exert via PR-B would be blocked by the dominant negative effect of excess PR-A (Meyer et al., 1990) . This gives scientific support to the medical treatment of uterine leiomyomata with RU 486 since this acts as an antagonist when bound to PR-A. Also the dominance of PR-A annuls the agonist-like effects of antagonist-occupied receptor B. Thus the effects of this agent will be those of antagonist.
The consistent observation that PR amounts are higher in leiomyomata than in adjacent myometrium (for example, this amounts of mRNA encoding PR measured in these two tissues ( Figure 5 ). Also we found there was no difference in the amounts of PR-A and PR-B mRNA. Thus there was no and PR-B and also the mRNA encoding these proteins in both myometrium and leiomyomata.
relationship between abundance of the PR-mRNA and immunoreactive protein content. The absence of any significant Our results show that there is a significant increase in total PR in leiomyomata compared to normal myometrium. This difference between PR-mRNA in leiomyomata and myometrium has been previously reported (Vollenhoven et al. , was determined by immunocytochemistry and Western blotting. This supports the view that progesterone plays a role in 1994) and these authors also detected an elevation in progesterone binding in leiomyomata. Our data suggest that PR activity fibroid growth. One hypothesis to explain this would be that leiomyomata escape completely from oestrogen regulation.
can be regulated post-transcriptionally (and possibly posttranslationally) and this is in addition to the differential This is supported by the observation that PR is elevated in breast carcinoma cells cultured in the absence of oestrogen transcription from the two promoters. Although the mechanism which determines PR levels but in medium containing a high concentration of insulin (Katzenellenbogen and Norman, 1990) , and the description of remains to be established, and there was some apparent variation in the intensity of nuclear staining in both tissues, the absence of PR in breast carcinoma tissues in presence of oestrogen (Reiner and Katzenellenbogen, 1986; Rio et al., the high receptor content of leiomyomata seems likely to be crucial for the growth of fibroid. However we have not been 1987; Savouret et al., 1991) .
An alternative hypothesis would be that the leiomyomata able to detect concordance between the cells positive for PR and the proliferative marker Ki-67 by double immunofluoresare hypersensitive to oestrogen, and become independent of ovarian oestrogen production which would result in a permanence (data not shown) in either leiomyomata or myometrium. This could be explained if the action of progesterone was ent high concentration of PR. The leiomyomata hormonal milieu could also be hyperoestrogenic. For example the presmediated by local growth factors through paracrine or autocrine action. This is supported by the observation that shrinkage of ence of specific receptors for oestradiol and metabolism of oestrogen has been demonstrated in leiomyomata (Reddy and uterine fibroid with GnRH agonists is associated with a
